BamSEC and AlphaSense Join Forces
Learn More

GT Biopharma Inc. – Articles of Incorporation

NASDAQ: GTBP    
Share price (10/1/26): $6.20    
Market cap (10/1/26): $11.2 million
Search in Documents
Key Exhibits
External Links

Articles of Incorporation Filter

EX-3.1
from 8-K 1 page GT Biopharma, Inc. Certificate of Increase of the Designated Number of Shares of Series M 10% Convertible Preferred Stock Pursuant to Section 151(g) of the General Corporation Law of the State of Delaware
12/34/56
EX-3.1
from 8-K 24 pages GT Biopharma, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series M 10% Convertible Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law
12/34/56
EX-3.12
from 8-K 2 pages Certificate of Amendment of Restated Certificate of Incorporation of GT Biopharma, Inc
12/34/56
EX-3.11
from 8-K 2 pages Certificate of Elimination of Series K Preferred Stock of GT Biopharma, Inc. (Pursuant to Section 151(g) of the Delaware General Corporation Law)
12/34/56
EX-3.10
from 8-K 2 pages Certificate of Elimination of Series J-1 Preferred Stock of GT Biopharma, Inc. (Pursuant to Section 151(g) of the Delaware General Corporation Law)
12/34/56
EX-3.9
from 8-K 2 pages Certificate of Elimination of Series I Preferred Stock of GT Biopharma, Inc. (Pursuant to Section 151(g) of the Delaware General Corporation Law)
12/34/56
EX-3.8
from 8-K 2 pages Certificate of Elimination of Series H Preferred Stock of GT Biopharma, Inc. (Pursuant to Section 151(g) of the Delaware General Corporation Law)
12/34/56
EX-3.7
from 8-K 2 pages Certificate of Elimination of Series G Preferred Stock of GT Biopharma, Inc. (Pursuant to Section 151(g) of the Delaware General Corporation Law)
12/34/56
EX-3.6
from 8-K 2 pages Certificate of Elimination of Series F Preferred Stock of GT Biopharma, Inc. (Pursuant to Section 151(g) of the Delaware General Corporation Law)
12/34/56
EX-3.5
from 8-K 2 pages Certificate of Elimination of Series E Preferred Stock of GT Biopharma, Inc. (Pursuant to Section 151(g) of the Delaware General Corporation Law)
12/34/56
EX-3.4
from 8-K 2 pages Certificate of Elimination of Series D Preferred Stock of GT Biopharma, Inc. (Pursuant to Section 151(g) of the Delaware General Corporation Law)
12/34/56
EX-3.3
from 8-K 2 pages Certificate of Elimination of Series C Preferred Stock of GT Biopharma, Inc. (Pursuant to Section 151(g) of the Delaware General Corporation Law)
12/34/56
EX-3.2
from 8-K 2 pages Certificate of Elimination of Series B Preferred Stock of GT Biopharma, Inc. (Pursuant to Section 151(g) of the Delaware General Corporation Law)
12/34/56
EX-3.1
from 8-K 2 pages Certificate of Elimination of Series a Preferred Stock of GT Biopharma, Inc. (Pursuant to Section 151(g) of the Delaware General Corporation Law)
12/34/56
EX-3.1
from 8-K 2 pages Amendment No. 1 to the Amended and Restated Bylaws of GT Biopharma, Inc
12/34/56
EX-3.1
from 8-K ~1 page GT Biopharma, Inc. Certificate of Increase of the Designated Number of Shares of Series L 10% Convertible Preferred Stock Pursuant to Section 151(g) of the General Corporation Law of the State of Delaware
12/34/56
EX-3.1
from 8-K 27 pages GT Biopharma, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series L 10% Convertible Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law
12/34/56
EX-3.1
from 8-K 1 page Certificate of Amendment of Restated Certificate of Incorporation of GT Biopharma, Inc
12/34/56
EX-3.2
from 10-Q 1 page Certification to Section 906 of the Sarbanes-Oxley Act of 2002
12/34/56
EX-3.5
from 10-K 2 pages Articles of Incorporation or Bylaws
12/34/56